ALS Limited (ASX Code: ALQ) advises that Mr Raj Naran will be the Company’s next CEO and Managing Director, succeeding Greg Kilmister who will retire from the Company at the conclusion of the 2017 Annual General Meeting on July 20 after 36 years with the Company, including 12 years as CEO.
With immediate effect Mr Naran will assume the role of Deputy CEO and will work alongside Greg Kilmister as he hands over his responsibilities to Raj over the coming months. Mr Naran will join the Board as CEO & Managing Director at the conclusion of the 2017 Annual General Meeting. In the meantime, he will also maintain his current role as head of ALS’ Life Sciences division.
Commenting on the appointment, ALS Chairman Bruce Phillips said “Over the last nine months a comprehensive process has been underway to prepare for Greg’s succession, including a major global talent search conducted with the assistance of the Korn Ferry group. We are delighted an ALS executive so strongly committed to the Company’s culture has emerged as the best candidate to succeed Greg.”
“As part of the succession process, Raj has also recently been leading a review of the Company’s 5-year strategic plan, a role that will continue until his formal appointment as CEO.”
Raj Naran was a founder of e-Lab Analytical Inc. which operated an environmental analytical testing business in Texas and Michigan, USA until it was acquired in 2007 by ALS. Raj was appointed to lead ALS’ USA Environmental business at that time and grew his role over the subsequent years to lead the global Life Sciences Division.
During his ten-year tenure with the division, Revenue has increased from A$165 million to A$634 million; EBIT from A$24 million with a 15% ROS, to A$110 million and a 17% ROS, and headcount increased from 1,500 to more than 6,500 people.
Mr Phillips added “Raj’s leadership qualities have been well demonstrated during the significant growth of the Life Sciences division. His strong focus on profitability and delivering on customer needs, through both organic growth and M&A activity have delivered substantial gains for ALS shareholders.”
Mr Naran responded to the news saying “It is an honour, privilege and great responsibility to be appointed the next Managing Director and CEO of ALS. I look forward to working with the ALS team to build on the achievements of my predecessors.”
Mr Phillips also paid tribute to Mr Kilmister’s leadership as Managing Director. “Greg has dedicated his business life to building ALS. He has been the pivotal force in the growth and transformation of the Company from a diversified industrial group to a globally respected Testing, Inspection & Certification (TIC) player and an ASX100 company. During his tenure as CEO, the Company’s market
cap has grown 705% from $ 381 million in 2005 to $ 3.1 billion today. His legacy will never be forgotten.”
Mr Kilmister said “It has been a privilege to lead an exceptional team of talented people in building ALS from 4,000 staff in 2005 to in excess of 13,000 today. ALS is a unique Australian company and I have every confidence that Raj will lead the company to an even brighter future. I look forward to working with Raj and the board to ensure a smooth transition in the months ahead.”
The material terms of Mr Naran’s appointment and his profile are set out in the attachments.
Dianne Richardson, Executive Assistant to MD +61 (7) 3367 7900
About ALS Limited
ALS is a global Testing, Inspection & Certification business. The company's strategy is to
broaden its exposure into new sectors and geographies where it can take a leadership position.